Guggenheim Capital’s Immunomedics Inc IMMU Stock Holding History

Guggenheim Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-86,381	Closed	-$7.34M	–	2157
2020 Q3	$7.34M	Sell	86,381 -54,262	-39%	-$2.74M	0.05%	381
2020 Q2	$4.99M	Sell	140,643 -7,439	-5%	-$217K	0.04%	519
2020 Q1	$2M	Sell	148,082 -29,188	-16%	-$491K	0.02%	789
2019 Q4	$3.75M	Buy	177,270 +26,377	+17%	+$465K	0.03%	766
2019 Q3	$2M	Sell	150,893 -38,021	-20%	-$559K	0.02%	1017
2019 Q2	$2.62M	Buy	188,914 +10,336	+6%	+$156K	0.02%	945
2019 Q1	$3.43M	Buy	178,578 +9,684	+6%	+$156K	0.03%	811
2018 Q4	$2.41M	Sell	168,894 -4,999	-3%	-$99.2K	0.02%	943
2018 Q3	$3.62M	Buy	173,893 +8,531	+5%	+$202K	0.02%	914
2018 Q2	$3.91M	Sell	165,362 -20,053	-11%	-$403K	0.03%	867
2018 Q1	$2.71M	Sell	185,415 -19,965	-10%	-$326K	0.01%	1416
2017 Q4	$3.32M	Buy	+205,380	New	+$2.42M	0.01%	1277

Guggenheim Capital's IMMU Position: Q4 2020 in Review

Guggenheim Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 86,381 shares — an estimated $7.34M sold.

Guggenheim Capital first reported a position in IMMU in Q4 2017 and held it in 12 quarters. The position peaked at $7.34M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Guggenheim Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Guggenheim Capital sold 86,381 Immunomedics Inc shares in Q4 2020, an estimated $7.34M.
Guggenheim Capital first reported a position in Immunomedics Inc in Q4 2017 and held it in 12 quarters.
Guggenheim Capital's Immunomedics Inc position peaked at $7.34M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Guggenheim Capital's 13F filing for Q4 2020, filed 16 Feb 2021.